• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharmaceuticals

Astellas Pharma Inc

+ Add to Watchlist


13.2400 USD 0.1700 1.30%

As of 20:10:00 ET on 07/11/2014.

Snapshot for Astellas Pharma Inc (ALPMY)

Open: 13.2390 Day's Range: 13.2300 - 13.3100 Volume: 10,897
Previous Close: 13.0700 52wk Range: 9.7440 - 13.4000 1-Yr Rtn: +18.60%

Stock Chart for ALPMY

No chart data available.
  • ALPMY:US 13.2400
  • 1D
  • 1M
  • 1Y
Interactive ALPMY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ALPMY

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 30,251.06
Shares Outstanding (M) 2,284.82
30 Day Average Volume 58,324
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 2.08%
Cash Dividend (USD) 0.1093
Dividend Ex-Date 03/26/2014
5 Year Dividend Growth 13.56%
Next Earnings Announcement 08/01/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ALPMY

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for ALPMY

Astellas Pharma Inc. is a pharmaceutical company committed to the therapeutic fields of Urology, Immunology including Transplantation and Infectious Diseases, Oncology, Neuroscience and DM Complications and Metabolic Diseases. With over 17,000 global employees, Astellas researches, develops, manufactures, and promotes its prescription drugs through subsidiaries in the US, Europe, and Asia

Masafumi NogimoriChairmanYoshihiko HatanakaPresident/CEO
Yoshiro MiyokawaExecutive Vice PresidentKenji YasukawaSenior VP/Chief Strategy Officer
More Company Profile & Key Executives for ALPMY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil